On 10 September 2025, the European Medicines Agency (EMA) announced two major updates for Marketing Authorisation Holders (MAHs): extended deadlines for PMS data submissions and the release of new PMS functionalities. While the extended timelines give companies more time to prepare, the upcoming PUI and API capabilities provide powerful tools to simplify and accelerate non-CAPs data enrichment. Together, these changes represent a significant shift in how MAHs manage regulatory data, offering both relief and new opportunities. We have collected them here:
In response to challenges raised by industry stakeholders, EMA has updated several PMS submission milestones:
These extensions give MAHs additional time to align processes, systems, and resources with new PMS requirements while maintaining pressure to ensure high-quality, structured data.
To help industry adapt to these new features, EMA is offering dedicated webinars in October 2025:
Additional resources are available on the PLM Portal, including the PMS Product UI registration guide, PMS Product UI navigation guide, and the PMS API Implementation Guide based on FHIR standards.
What do the extended PMS deadlines and its new functionalities mean for MAHs?
These two developments - extended deadlines and new functionalities - are closely linked. On one hand, MAHs gain more time to meet PMS requirements; on the other, they now have more powerful tools to make compliance easier and more efficient.
For MAHs, the key takeaways are:
EMA’s announcement marks an important step in shaping the future of regulatory data management. While the extended deadlines provide breathing space, the release of PUI and API functionalities signals that the transition to structured, digital-first regulatory data is accelerating. MAHs that act early - leveraging the new tools and preparing their systems now - will be best positioned to stay compliant and competitive.